
Rosana Kapeller listening to a member on the breakfast panel at #BIO19 discuss AI in R&D in Philadelphia (Jeff Rumans for Endpoints News)
Nimbus founder Rosana Kapeller has a new company, with $50M and an eye on the ‘repeatome’
Rosana Kapeller left Nimbus two years ago determined, after 2 decades and 3 companies, that her next spot would be as CEO. Today, after a 7-month sabbatical and a stint at a top VC firm, the jocular computational biology pioneer is back. And with full control.
“I really wanted to… make a unique organization, a unique culture,” Kapeller told Endpoints News. “I wanted that challenge.”
And a challenge it will be, both scientifically and because, well, there’s a pandemic keeping much of her 10-person team working from her home. “This is a hard time to start a company,” she acknowledged.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters